» Articles » PMID: 26152684

Realizing the Potential of Clinical Risk Prediction Models: Where Are We Now and What Needs to Change to Better Personalize Delivery of Care?

Overview
Date 2015 Jul 9
PMID 26152684
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

(Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient's knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study).

Kruiswijk A, van de Sande M, Haas R, van den Akker-van Marle E, Engelhardt E, Marang-van de Mheen P BMJ Open. 2023; 13(11):e074853.

PMID: 37918933 PMC: 10626817. DOI: 10.1136/bmjopen-2023-074853.


The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration.

Kent D, van Klaveren D, Paulus J, DAgostino R, Goodman S, Hayward R Ann Intern Med. 2019; 172(1):W1-W25.

PMID: 31711094 PMC: 7750907. DOI: 10.7326/M18-3668.


Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects.

Kent D, Steyerberg E, van Klaveren D BMJ. 2018; 363:k4245.

PMID: 30530757 PMC: 6889830. DOI: 10.1136/bmj.k4245.


Big data analytics to improve cardiovascular care: promise and challenges.

Rumsfeld J, Joynt K, Maddox T Nat Rev Cardiol. 2016; 13(6):350-9.

PMID: 27009423 DOI: 10.1038/nrcardio.2016.42.